Director, Transplant Infectious Disease
Infectious Disease
Dr. Markian R. Bochan, MD
|
|
Give Review
Markian Bochan works in the field of Infectious Disease. He attended Indiana University School of Medicine. Indiana University School of Medicine is ranked 45/47 in Research/PrimaryCare. He over the years received 1 awards: "Indianapolis Monthly". Doctor Markian R. Bochan, MD is a published physician as well. He has 19 publications published. The latest was: Clinical experience with autologous and allogeneic pancreatic islet transplantation. Markian R. Bochan, MD accepts Medicare payments and is listed with Medicare.gov.
Publications
- Reducing the activity and secretion of microbial antioxidants enhances the immunogenicity of BCG.
- Increase in tumor necrosis factor-alpha mRNA but not perforin mRNA expression in response to two newly characterized anti-LFA-1 monoclonal antibodies.
- Target cell-directed degradation of perforin mRNA in CTL: lack of correlation with loss of protein and lytic ability.
- Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancom...
- Iron-cofactored superoxide dismutase inhibits host responses to Mycobacterium tuberculosis.
- Reversal of diabetes in the rat by injection of hematopoietic stem cells infected with recombinant adeno-associated virus containing the preproinsulin II gene.
- Reversal of diabetes in streptozotocin-treated rats by intramuscular injection of recombinant adeno-associated virus containing rat preproinsulin II gene.
- Clinical experience with autologous and allogeneic pancreatic islet transplantation.
- Stable transduction of human pancreatic adenocarcinoma cells, rat fibroblasts, and bone marrow-derived stem cells with recombinant adeno-associated virus containing th...
- Granzyme B independently of perforin mediates noncytolytic intracellular inactivation of vesicular stomatitis virus.
- Construction of recombinant adeno-associated virus vector containing the rat preproinsulin II gene.
- Synergistic inhibition of human cell-mediated cytotoxicity by complement component antisera indicates that target cell lysis may result from an enzymatic cascade invol...
- Human granzyme B is essential for DNA fragmentation of susceptible target cells.
- The lack of NK cytotoxicity associated with fresh HUCB may be due to the presence of soluble HLA in the serum.
- Target cell-directed rapid degradation of TNF-alpha messenger RNA in human cytotoxic T cells.
- Stably transfected antisense granzyme B and perforin constructs inhibit human granule-mediated lytic ability.
- Fas-mediated cytotoxicity remains intact in perforin and granzyme B antisense transfectants of a human NK-like cell line.
- Fas involvement in cytotoxicity mediated by human NK cells.
Schools
Indiana University School Of Medicine
St Vincent Hospital
Vanderbilt University
Indiana University Microbiology Graduate School
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
- Choice Plus POS II
- MHS HIX
- Anthem Blue Cross Blue Shield HMO
- Anthem Blue Cross Blue Shield PPO
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Cofinity PPO
- Commercial Insurance Company
- Emblem Health
- Medicare Advantage PFFS
- Choice Care PPO
- Mail Handlers Benefit Plan (MHBP)
- Medicaid
- Medical Mutual of Ohio
- Medicare MCR
- Medico
- MultiPlan PPO
- PHCS Network PPO
- Pyramid Life
- Sagamore Plus
- Saint Francis Health Network
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- Indianapolis Monthly
Education
-
Vanderbilt University -
St Vincent Hospital and Health Care Center -
Indiana University School of Medicine
Drug Facts
| NPI NUMBER | 1972541936 | |
| NPPES Provider LastName | BOCHAN | |
| NPPES Provider FirstName | MARKIAN | |
| NPPES Provider ZIPCode | 460321624 | |
| NPPES Provider State | IN | |
| Specialty Description | Infectious Disease | |
| Total Claim Count | 843.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1972541936 |
| Last Name Of The Provider | BOCHAN |
| First Name Of The Provider | MARKIAN |
| View All |
Similar Doctors
|
|
Dr. George M. Vail, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Karen S. Israel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Diane M. Janowicz, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Eva W. Muloma, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Janet N. Arno, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lawrence J. Wheat, MD |
|
|
Dr. Jaffar A. Al-Tawfiq, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carol L. Langley, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Virginia A. Caine, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tracey R. Ikerd, MD
This Doctor is OpenDoctor Recommended.
|